ATE118015T1 - Biologisch aktive polypeptide, die auf transformierten wachstumsfaktor-beta-sequenzen basieren. - Google Patents
Biologisch aktive polypeptide, die auf transformierten wachstumsfaktor-beta-sequenzen basieren.Info
- Publication number
- ATE118015T1 ATE118015T1 AT90908073T AT90908073T ATE118015T1 AT E118015 T1 ATE118015 T1 AT E118015T1 AT 90908073 T AT90908073 T AT 90908073T AT 90908073 T AT90908073 T AT 90908073T AT E118015 T1 ATE118015 T1 AT E118015T1
- Authority
- AT
- Austria
- Prior art keywords
- leu
- arg
- polypeptide
- tgf
- cys
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/356,964 US5061786A (en) | 1989-05-25 | 1989-05-25 | Biologically active polypeptides based on transforming growth factor-β |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE118015T1 true ATE118015T1 (de) | 1995-02-15 |
Family
ID=23403710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90908073T ATE118015T1 (de) | 1989-05-25 | 1990-04-04 | Biologisch aktive polypeptide, die auf transformierten wachstumsfaktor-beta-sequenzen basieren. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5061786A (de) |
EP (1) | EP0473649B1 (de) |
AT (1) | ATE118015T1 (de) |
CA (1) | CA2057896C (de) |
DE (1) | DE69016655T2 (de) |
ES (1) | ES2070322T3 (de) |
WO (1) | WO1990014359A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4958590A (en) * | 1988-12-05 | 1990-07-10 | Trustees Of Columbia University In The City Of New York, The | Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof |
US5422340A (en) * | 1989-09-01 | 1995-06-06 | Ammann; Arthur J. | TGF-βformulation for inducing bone growth |
GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
US5436228A (en) * | 1990-12-12 | 1995-07-25 | Postlethwaite; Arnold E. | Chemotactic wound healing peptides |
US5824647A (en) * | 1990-12-12 | 1998-10-20 | Postlethwaite; Arnold E. | Chemotactic wound healing peptides |
GB9106678D0 (en) * | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
US7067637B1 (en) * | 1992-02-12 | 2006-06-27 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Antibody or antibody fragments specific for a protein of the TGF-β family |
DK0695189T3 (da) | 1992-12-29 | 1999-08-09 | Genentech Inc | Behandling af inflammatorisk tarmsygdom med IFN-gammainhibitorer |
EP0690871A4 (de) * | 1993-01-12 | 1999-10-20 | Univ Johns Hopkins Med | Wachstums-differenzierungsfaktor-5 |
US5420243A (en) * | 1993-01-26 | 1995-05-30 | Celtrix Pharmaceuticals, Inc. | Biologically active TGF-β2 peptides |
AU697916B2 (en) * | 1993-01-26 | 1998-10-22 | Celtrix Pharmaceuticals, Inc. | Biologically active TGF-beta1 and TGF-beta2 peptides |
CA2149528A1 (en) * | 1993-09-29 | 1995-04-06 | Billie M. York | Compositions containing growth factors and antimetabolites |
US5411940A (en) * | 1993-09-29 | 1995-05-02 | Alcon Laboratories, Inc. | Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma |
AU7846894A (en) * | 1993-09-29 | 1995-04-18 | Alcon Laboratories, Inc. | Compositions containing growth factors and antiplastic agents |
TW517059B (en) * | 1994-07-25 | 2003-01-11 | Ciba Geigy Ag | New process for the production of biologically active protein |
TW440566B (en) * | 1994-07-25 | 2001-06-16 | Novartis Ag | Novel process for the production of biologically active dimeric protein |
US5616561A (en) * | 1995-03-31 | 1997-04-01 | Regents Of The University Of California | TGF-β antagonists as mitigators of radiation-induced tissue damage |
US6040431A (en) | 1995-06-07 | 2000-03-21 | Stryker Corporation | Single chain analogs of the TGF-β superfamily (morphons) |
US20030185792A1 (en) * | 1996-01-22 | 2003-10-02 | Curis, Inc. | Morphogen analogs of bone morphogenic proteins |
WO1997026277A2 (en) | 1996-01-22 | 1997-07-24 | Creative Biomolecules, Inc. | Morphogen analogs and methods for producing them |
EP0877031A1 (de) * | 1997-05-06 | 1998-11-11 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Von TGF-Beta1 abgeleiteten Peptiden mit TGF-Beta1 ähnlicher Aktivität |
DE69933216T2 (de) | 1998-06-15 | 2007-09-20 | GTC Biotherapeutics, Inc., Framingham | Erythropoietin-analog-menschliches serum-albumin fusionsprotein |
DE19906096A1 (de) | 1999-02-13 | 2000-08-17 | Walter Sebald | Protein mit einem Heparin-bindenden Epitop |
US6703480B1 (en) * | 1999-11-24 | 2004-03-09 | Palani Balu | Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use |
WO2001049220A1 (en) | 1999-12-30 | 2001-07-12 | Osteotech, Inc. | Intervertebral implants |
US20030190322A1 (en) * | 2000-03-31 | 2003-10-09 | Peter Kaastrup | Immunostimulating properties of a fragment of tgf-beta |
WO2001072331A1 (en) * | 2000-03-31 | 2001-10-04 | Vaccine Chip Technology Aps | Immunostimulating properties of a fragment of tgf-beta |
US6638310B2 (en) | 2000-07-26 | 2003-10-28 | Osteotech, Inc. | Intervertebral spacer and implant insertion instrumentation |
US20030120274A1 (en) | 2000-10-20 | 2003-06-26 | Morris John W. | Implant retaining device |
US6908899B2 (en) * | 2001-08-17 | 2005-06-21 | U.S. Dept. Of Veterans Affairs | Pro-inflammatory fibrinopeptide |
US6855167B2 (en) | 2001-12-05 | 2005-02-15 | Osteotech, Inc. | Spinal intervertebral implant, interconnections for such implant and processes for making |
US20040028661A1 (en) * | 2002-08-07 | 2004-02-12 | Bartelmez Stephen H. | Expansion of cells using thrombopoietin and anti-transforming growth factor-beta |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
EP1697415A1 (de) | 2003-11-12 | 2006-09-06 | Biogen Idec MA Inc. | Polypeptidvarianten, die an den neonatal-fc-receptor (fcrn) binden, dimere fc-bindende proteine und damit in zusammenhang stehende verfahren |
AU2005209304B2 (en) | 2004-01-27 | 2010-08-26 | Warsaw Orthopedic, Inc. | Stabilized bone graft |
RU2386638C2 (ru) | 2004-03-31 | 2010-04-20 | Дженентек, Инк. | Гуманизированные анти-тфр-бета-антитела |
EP1768662A2 (de) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Immunstimulatoren kleiner moleküle und assays für deren nachweis |
ES2408704T3 (es) | 2005-01-05 | 2013-06-21 | Biogen Idec Ma Inc. | Moléculas de unión a Cripto |
USD580551S1 (en) * | 2007-02-01 | 2008-11-11 | Zimmer Spine, Inc. | Spinal implant |
WO2008100856A2 (en) | 2007-02-12 | 2008-08-21 | Osteotech, Inc. | Joint revision implant |
EP2591006B1 (de) | 2010-07-09 | 2019-04-24 | Bioverativ Therapeutics Inc. | Verarbeitbare einkettige moleküle und daraus hergestellte polypeptide |
US9738707B2 (en) | 2011-07-15 | 2017-08-22 | Biogen Ma Inc. | Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto |
PL2802606T3 (pl) | 2012-01-10 | 2018-09-28 | Biogen Ma Inc. | Udoskonalenie transportu cząsteczek terapeutycznych przez barierę krew-mózg |
EP3254104B1 (de) | 2015-02-04 | 2021-08-25 | Bristol-Myers Squibb Company | Verfahren zur auswahl therapeutischer moleküle |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816449A (en) * | 1984-08-09 | 1989-03-28 | Immunetech Pharmaceuticals | Immunotherapeutic anti-inflammatory peptide agents |
US4843063A (en) * | 1984-07-16 | 1989-06-27 | Collagen Corporation | Polypeptide cartilage-inducing factors found in bone |
ATE128715T1 (de) * | 1984-07-16 | 1995-10-15 | Celtrix Pharma | Polypeptide induzierende faktoren in knochen und knorpel. |
NZ222168A (en) * | 1986-10-20 | 1991-05-28 | Oncogene Science Inc | Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions |
US4816442A (en) * | 1986-11-07 | 1989-03-28 | Collagen Corporation | Method of inhibiting tumor growth sensitive to CIF-βtreatment |
AU1366088A (en) * | 1987-01-28 | 1988-08-24 | Ortho Pharmaceutical Corporation | Immunosuppressive peptides and methods of use |
US4931548A (en) * | 1987-01-30 | 1990-06-05 | Techne Corporation | Heterodimer form of transforming growth factor-beta |
AU1539188A (en) * | 1987-05-04 | 1988-11-10 | Bristol-Myers Squibb Company | TGF-B2 and novel compositions having anti-neoplastic activity |
-
1989
- 1989-05-25 US US07/356,964 patent/US5061786A/en not_active Expired - Lifetime
-
1990
- 1990-04-04 ES ES90908073T patent/ES2070322T3/es not_active Expired - Lifetime
- 1990-04-04 EP EP90908073A patent/EP0473649B1/de not_active Expired - Lifetime
- 1990-04-04 CA CA002057896A patent/CA2057896C/en not_active Expired - Lifetime
- 1990-04-04 DE DE69016655T patent/DE69016655T2/de not_active Expired - Lifetime
- 1990-04-04 WO PCT/US1990/001826 patent/WO1990014359A1/en active IP Right Grant
- 1990-04-04 AT AT90908073T patent/ATE118015T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2057896A1 (en) | 1990-11-26 |
DE69016655D1 (de) | 1995-03-16 |
EP0473649B1 (de) | 1995-02-01 |
US5061786A (en) | 1991-10-29 |
ES2070322T3 (es) | 1995-06-01 |
CA2057896C (en) | 2000-06-06 |
DE69016655T2 (de) | 1995-08-17 |
WO1990014359A1 (en) | 1990-11-29 |
EP0473649A1 (de) | 1992-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69016655D1 (de) | Biologisch aktive polypeptide, die auf transformierten wachstumsfaktor-beta-sequenzen basieren. | |
ATE168719T1 (de) | Osteogene peptide | |
ATE116335T1 (de) | Peptid-analoge vom insulinähnlichen wachstums- faktor 1 (igf-1) oder faktor 2 (igf-2). | |
ATE123949T1 (de) | B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung. | |
DE69132275D1 (de) | Beta-type ähnlicher transformierender wachstumfaktor | |
RU93045577A (ru) | Слитные полипептиды | |
BR9306272A (pt) | Peptídeo e composiçao farmacêutica | |
ES2196088T3 (es) | Analogos del factor de crecimiento de los queratinocitos. | |
DE69029377D1 (de) | Substituierungsanaloge von magaininpeptiden | |
ES2044928T3 (es) | Enzima alfa-amidante en terminal c y procedimiento para la produccion y el uso del mismo. | |
WO1989001490A3 (en) | Biologically active molecules | |
KR930004326A (ko) | 콘드로모듈린-ii 단백질 | |
ATE432985T1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
SE9101586D0 (sv) | Modified thioredoxin and its use | |
DK56995A (da) | Rekombinante lymphotoxin-varianter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |